Gene Therapy Market Research Reports & Industry Analysis
Gene therapy is an innovative field with the potential to develop new, personalized medical treatments for previously challenging conditions. At MarketResearch.com, we are committed to providing you with comprehensive gene therapy industry reports that shed light on this fast-growing market.
Understanding the Gene Therapy Market
- Our gene therapy market research reports provide valuable insights into this dynamic field to help you understand the key factors at play, prepare for challenges, and leverage technological advancements.
- Our research collection covers various markets—such as gene therapy, precision medicine, delivery devices, and manufacturing services—with data on market size and growth projections.
- In addition, we also delve into market segmentation, key developments, industry trends, and company profiling to give you the full picture of the market.
Helping You Stay Ahead
Whether you're an experienced industry professional, a consultant, or a busy executive, our gene therapy market research reports provide valuable insights. These reports are based on reliable data and expert analysis to help you make informed business decisions. With MarketResearch.com, you can stay ahead of the competition and take advantage of emerging market opportunities.
Gene Therapy Industry Research & Market Reports
-
Cell and Gene Therapy Deals: Financings, Partnering, M&A, Technology Transfers, IPOs, and Other Developments
... A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently. There are now many approved therapies with proven track records. As the tools have lowered the barriers ... Read More
-
Alpha Mannosidosis Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change Including: 1) By Therapy Type: Bone Marrow Transplant (BMT); Enzyme Replacement Therapy (ERT); Peripheral Blood Stem Cell Transplantation (PBSCT); Gene Therapy 2) By Indication: Type I; Type II; Type III 3) By End-User: Hospitals; Speciality Clinics Covering: Chiesi Farmaceutici S.p.A.
... alpha mannosidosis market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies. Understand how the ... Read More
-
Cell Therapy And Gene Therapy Markets
... Information presents the market in segments that provide an overview of disease epidemiology, market estimates and forecasts, and competitive summary of leading providers: Cell and Gene Therapy Market Summary by Product Segment, 2021-2031 ($ millions) ... Read More
-
AAV vectors in gene therapy – Pipeline Insight, 2022
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Nucleic Acid Based Gene Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change Including: 1) By Nucleic Acid Technology: Anti-Sense And Anti-Gene Oligonucleotides; Sirna And Rna Interference; Gene Transfer Therapy; Ribozymes; Aptamers; Others 2) By Application: Oncology; Muscular Dystrophy/ Muscular Disorders; Rare Diseases; Others 3) By End User: Hospitals And Clinics; Academic And Research Institutes Covering: Copernicus Therapeutics; Moderna Inc.; Wave Life Sciences; Protagonist Therapeutics; Transgene
... assess the global nucleic acid based gene therapy market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market ... Read More
-
Global Erectile Dysfunction Market Insights, Forecast to 2028
... million in 2021 and is forecast to a readjusted size of US$ 226.53 million by 2028 with a CAGR of 8.54% during 2022-2028. The global main manufacturers of GMP Cytokines include Miltenyi Biotec, Bio-Techne, Cytiva, ... Read More
-
Global Gene Synthesis Market By Method (Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis), By Service Type (Antibody DNA Synthesis, Viral DNA Synthesis and Others), By Application (Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others), By End User (Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027
... Diagnosis and Others), By End User (Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 The Global Gene Synthesis Market ... Read More
-
U.K. Cell and Gene Therapy Research Challenges Market, by Therapy Type (Cell Therapy (Stem Cells, T Cells, Dendritic Cells, and NK Cells) and Gene Therapy (Germline Gene Therapy and Somatic Gene Therapy)), and by Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Cell therapy can be defined as the transfer of new cells into a patient’s body to ... Read More
-
Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027
... therapy market size was valued at USD 4.99 billion in 2021 and is expected to reach USD 36.92 billion by 2027, growing at a CAGR of 39.62 % during the forecast period The following factors ... Read More
-
Cell & Gene Therapy Manufacturing Services Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)
... forecast period. During the COVID 19 pandemic, the Cell & Gene Therapy Manufacturing Services Market was adversely affected. There were two primary reasons for that, the limited running capacity protocols introduced by the governments and ... Read More
-
Microcarrier Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... biosimilar industry, and increasing R&D and availability of funding for cell therapy research. Many of the current biologics in the pipeline are targeting the indications, which are small-molecule dominated and have a large patient pool. ... Read More
-
Global Osteoarthritis Gene Therapy Market Size study, by Site of Injection (Synovium, Cartilage) by Vectors (Non-viral, Retrovirus, Lentivirus, Adenovirus, Adeno-associated virus (AAV), HSV) by end use industries (Hospitals and clinics, Orthopedic Centers, Assisted living Facilities, Nursing, Homes, Ambulatory Surgical Centers, Others) and Regional Forecasts 2021-2027
... Nursing, Homes, Ambulatory Surgical Centers, Others) and Regional Forecasts 2021-2027 Global Osteoarthritis Gene Therapy Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Gene And Cell Therapies In Rare Disorder - Market Insight, Epidemiology and Market Forecast -2032
... well as the Gene And Cell Therapies In Rare Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Gene And Cell Therapies In Rare Disorder market ... Read More
-
Gene Therapy for Ocular Rare Disease - Epidemiology Forecast - 2032
... i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: ... Read More
-
Adeno-Associated Virus Vectors in Gene Therapy - Market Insight, Epidemiology and Market Forecast -2032
... the Adeno-Associated Virus Vectors in Gene Therapy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Adeno-Associated Virus Vectors in Gene Therapy market report provides current treatment ... Read More
-
Adeno-Associated Virus (AAV) Vectors in Gene Therapy - Epidemiology Insight - 2032
... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More
-
Gene Therapies for Cardiomyopathies - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Gene Therapies for ... Read More
-
Gene therapy for ocular rare disease Market Insights, Competitive Landscape and Market Forecast–2026
... therapy for ocular rare disease and the historical and forecasted Gene therapy for ocular rare disease market trends, globally, which comprises of North America, Europe, APAC, and RoW. The Gene therapy for ocular rare disease ... Read More
-
Gene therapy in rare diseases - Epidemiology Forecast - 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Gene ... Read More
-
Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast - 2032
... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More
-
Rare Disease & Orphan Therapeutic Market Analysis & Forecast to 2025
... Cell Therapy (ACT) & IDO Inhibitors This industry analysis report tackles the major orphan drugs within the rare disease therapeutic market and encompasses the most prevalent and dominant therapies in this space. The market value ... Read More
-
Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2025- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
... industry and its impact on the health system. This report tackles the growing market interest in pharmacogenomics, targeted therapeutics, companion diagnostics and the associated market environment. In 2019, 11 personalized therapeutics gained approval from the ... Read More
-
Cell Therapy and Gene Therapy Markets
... products. Cell and gene therapy products are transforming the treatment of cancers and genetic diseases, as well as expanding into other areas of medicine including autoimmune diseases, cardiovascular diseases, musculoskeletal disease, dermatological diseases, and many ... Read More
-
Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape
... two years have seen the approval of four gene therapies by the FDA - (1) Luxturna, the first in vivo gene transfer therapy (2) Imlygic, an novel immunotherapy, (3) Kymriah and (4) Yescarta, two Chimeric ... Read More
Research Assistance
